Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The American Thrombosis and Hemostasis Network (ATHN) is a non-profit organization dedicated to advancing care for individuals with bleeding and clotting disorders. ATHN provides a national infrastructure for clinical data collection and management, supporting a network of over 145 federally funded hemophilia treatment centers (HTCs) across the United States. By maintaining a secure national database, ATHN facilitates large-scale research, clinical trials, and quality improvement initiatives aimed at improving outcomes for patients with hemophilia, von Willebrand disease, and other rare coagulation disorders. Their services include data stewardship, research support, and the development of digital health tools for patient monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Thrombosis.